Recruitment of naive CD4(+) T cells by the recombinant zoster vaccine correlates with persistent immunity

Herpes zoster (HZ) is a substantial problem for people with decreased cell-mediated immunity, including older adults. The first vaccine approved for HZ prevention, the zoster vaccine live (ZVL), which provided limited and short-lived protection, has been supplanted by the superior recombinant zoster...

Descripción completa

Detalles Bibliográficos
Autores principales: Laing, Kerry J., Ford, Emily S., Johnson, Michael J., Levin, Myron J., Koelle, David M., Weinberg, Adriana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688978/
https://www.ncbi.nlm.nih.gov/pubmed/37788096
http://dx.doi.org/10.1172/JCI172634

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688978/
https://www.ncbi.nlm.nih.gov/pubmed/37788096
http://dx.doi.org/10.1172/JCI172634

Ejemplares similares